To elucidate whether these PD-1-dependent metabolic and epigenetic changes are also present in human T cell lymphoma, we analyzed leukemic stage primary patient samples from cohorts of clinically annotated T-NHLs of cutaneous origin by isolating malignant lymphoma cells by flow cytometry. This evidence concerns the gene PDCD1 and T-cell non-Hodgkin lymphoma.